Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer

  • Randy Strong
  • , Richard A. Miller
  • , Adam Antebi
  • , Clinton M. Astle
  • , Molly Bogue
  • , Martin S. Denzel
  • , Elizabeth Fernandez
  • , Kevin Flurkey
  • , Karyn L. Hamilton
  • , Dudley W. Lamming
  • , Martin A. Javors
  • , João Pedro de Magalhães
  • , Paul Anthony Martinez
  • , Joe M. McCord
  • , Benjamin F. Miller
  • , Michael Müller
  • , James F. Nelson
  • , Juliet Ndukum
  • , G. Ed Rainger
  • , Arlan Richardson
  • David M. Sabatini, Adam B. Salmon, James W. Simpkins, Wilma T. Steegenga, Nancy L. Nadon, David E. Harrison

Producción científica: Articlerevisión exhaustiva

Huella

Profundice en los temas de investigación de 'Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer'. En conjunto forman una huella única.
Clasificar por

Medicine and Dentistry